| SF-36 scale |
Weeknumber |
Least squared mean of change
scores from baseline
(week 0) |
Difference (SE) |
P value |
| PF |
26 |
4.73 |
0.03 (0.54) |
0.955 |
| |
52 |
4.76 |
|
|
| RP |
26 |
4.01 |
0.37 (0.63) |
0.561 |
| |
52 |
4.38 |
|
|
| BP |
26 |
3.79 |
1.61 (0.65) |
0.014 |
| |
52 |
5.40 |
|
|
| GH |
26 |
1.37 |
0.35 (0.46) |
0.441 |
| |
52 |
1.72 |
|
|
| VT |
26 |
2.44 |
0.59 (0.54) |
0.274 |
| |
52 |
3.03 |
|
|
| SF |
26 |
2.06 |
0.33 (0.64) |
0.609 |
| |
52 |
2.38 |
|
|
| RE |
26 |
1.06 |
0.47 (0.76) |
0.539 |
| |
52 |
1.53 |
|
|
| MH |
26 |
1.78 |
0.45 (0.57) |
0.428 |
| |
52 |
2.23 |
|
|
| PCS |
26 |
4.38 |
0.64 (0.52) |
0.219 |
| |
52 |
5.02 |
|
|
| MCS |
26 |
0.50 |
0.35 (0.57) |
0.545 |
| |
52 |
0.85 |
|
|
|
| BP: bodily pain; GH: general health perceptions; MCS: mental component summary; MH: mental health; PCS: physical component summary; PF: physical functioning; RE: role limitations due to emotional problems; RP: role limitations due to physical health; SE: standard error; SF: social functioning; VT: vitality. |
| Table 2: Comparisons of the SF-36 change scores at weeks 26 and 52 in patients who received IA-BioHA during the FLEXX Trial and a repeat series of IA-BioHA in the Extension Study. |